🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchInsulin icodec (Awiqli) — need advice Page 5

Insulin icodec (Awiqli) — need advice

VendorMark Mon, Feb 2, 2026 at 1:53 AM 31 replies 1,494 viewsPage 5 of 7
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Feb 4, 2026 at 11:42 PM#21

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

1 24emily_PDX
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Feb 5, 2026 at 3:15 PM#22
Dr.NutriCornell said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Mine went the same way, slower. I had assumed I was the exception until I read this.

Last edited: Feb 5, 2026 at 5:15 PM
2 0Dr.ObesityLA, NurseKim_ATL
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Feb 6, 2026 at 6:48 AM#23
Dr.NutriCornell said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Coming at Dr.NutriCornell’s question from a different direction. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

3 1FDA_TrackerJim, ricardo_MIA, BrianDallas92
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Feb 6, 2026 at 10:21 PM#24

The figures, for anyone assembling their own picture. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

4 2Dr.PulmRoch, maya_sedona, stefan_berlin and 1 other
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Feb 7, 2026 at 1:53 PM#25

One thing that is still open after Dr.NutriCornell’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

5 3bbq_ray_KC, oliver_london, tane_welly and 2 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register